Vironna Pharm News Today : Breaking News, Live Updates & Top Stories | Vimarsana

IM Cannabis : Management s Discussion and Analysis Q2 2023

IM Cannabis Corp. Management s Discussion and Analysis For the Three and Six Months Ended June 30, 2023 August 14,. -Today at 10:29 am- MarketScreener

United statesH efaUnited kingdomVironna pharmPharm yarokAdjupharm gmbhI mc farms israel ltdRosen high way ltdInternational financial reporting standardsOranim plus pharm ltdI mc pharma ltdCanadian securities exchangeTrichome financial corpRa yarok pharm ltdHerbs ltdIm cannabis corp

IM Cannabis Corp: IM Cannabis Reports Fourth Quarter and Fiscal Year 2022 Financial Results; Revenues in 2022 Increased 60% Year-over-Year

Company to continue its focus on the Israeli and German markets with a primary goal of sustainably increasing revenue in each of these core markets and accelerating path to profitability, while actively

Israel generalOren shusterSde avrahamOranim pharmAdjupharm gmbVironna pharmPanaxia labs israel ltdOranim plus pharm ltdAcquisition corpPanaxia logistics ltdNutraceuticals incCanadian securities exchangeRosen high way ltdRa yarok pharm ltdPanaxia pharmaceutical industries israel ltdHerbs ltd

IM Cannabis Reports Fourth Quarter and Fiscal Year 2022 Financial Results; Revenues in 2022 Increased 60% Year-over-Year

/PRNewswire/ IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, today announced its financial.

Israel generalOranim pharmOren shusterSde avrahamAdjupharm gmbVironna pharmCompany contactCompany israeliMarketing ltdPanaxia logistics ltdIm cannabis corpTrichome financial corpPanaxia labs israel ltdHerbs ltdCanadian securities exchangeRosen high way ltd

IM Cannabis Q1 Revenue Increases 18% Sequentially to $23 6 Million

IM Cannabis Reports Record First Quarter 2022 Financial Results; Revenues Increase 169% YoY to $23.6 Million. Gross Profit Increased 37% from Q1 2021 as Operational. #imcannabis #IMCHoldings #imcc

Israel generalUnited statesVironna pharmOren shusterSde avrahamAdjupharm gmbhPharm yarokHerbs ltdRosen high way ltdIsraeli medical cannabis agencyCompany expects to achieve positive adjustedPanaxia labs israel ltdNutraceuticals incInternational financial reporting standardsIm cannabis corpAcquisition corp

IM Cannabis Corp Appoints Rinat Efrima as New Chief Executive Officer of IMC Holdings, the Company s Israeli Subsidiary

IM Cannabis Corp Appoints Rinat Efrima as New Chief Executive Officer of IMC Holdings, the Company s Israeli Subsidiary
theusnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theusnews.com Daily Mail and Mail on Sunday newspapers.

United statesH efaRinat efrimaYael harroshOren shusterAdjupharm gmbhKarl grywacheskiVironna pharmHoward steinbergPharm yarokMaya lustigRosen high way ltdHerbs ltdSublimeculture incOranim pharm partnershipKimberly clark corporation